stockportfolio.pro
Stocks / LMRI vs USPH
LMRI vs USPH
Lumexa Imaging Holdings, Inc. and U.S. Physical Therapy, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Lumexa Imaging Holdings, Inc. (LMRI) | U.S. Physical Therapy, Inc. (USPH) | |
|---|---|---|
| Market cap | $0.9B | $0.9B |
| Revenue (latest FY) | $1.02B | $780.99M |
| Net income (latest FY) | $-47.10M | $39.58M |
| Revenue growth (5y CAGR) | 4.6% | 13.0% |
| Net margin | -4.6% | 5.1% |
| Return on equity | -8.0% | 8.3% |
| P/E ratio | — | 124.5 |
| Dividend yield | — | 2.9% |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | No | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open LMRI — free Open USPH — freeFrequently asked questions
Which is bigger, LMRI or USPH?
U.S. Physical Therapy, Inc. is larger by market capitalization — $0.9B versus $0.9B.
Which grows faster, LMRI or USPH?
Over the last five fiscal years, U.S. Physical Therapy, Inc. grew revenue faster — 13.0%/yr versus 4.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.